Proving the eDiary Dividend, Applied Clinical Trials, June 2004

Summary

This article reviews the tangible value Sepracor Pharmaceuticals realized by capturing real-time PRO data with invivodata's eDiary system in a Phase III clinical trial. The authors demonstrate how increasing patient compliance reduced error variance, which increased the trial's sensitivity and provided a more reliable measurement of the drug's effectiveness.

Download " Proving the eDiary Dividend "